Should a computed tomography (CT) scan be ordered for every patient with trace hematuria on urinalysis?

No, CT Should Not Be Routinely Ordered for Trace Blood in Urinalysis

Patients without risk factors and with an identified benign cause of microhematuria (including vigorous exercise, infection, trauma, menstruation, or recent urologic procedure) are unlikely to gain any benefit from a complete imaging workup and should not undergo CT imaging 1.

Risk-Stratified Approach to Imaging

The decision to order CT imaging for trace hematuria depends entirely on risk stratification, not simply the presence of blood on urinalysis.

When CT Is NOT Indicated (Low-Risk Patients)

Do not order imaging if the patient has:

• Identified benign causes: vigorous exercise, urinary tract infection, trauma, menstruation, recent urologic procedure 1
• No risk factors for malignancy
• Trace/low-level microhematuria (3-10 RBCs/HPF) without risk factors 2

The malignancy risk in microhematuria without risk factors is only 2.6-4%, and in most cases no cause is ever found 1. Recent evidence shows that 99.4% of patients with microscopic hematuria had no upper urinary tract malignancies on CT urography, including all patients under 50 years old 3.

When CT Urography IS Indicated (High-Risk Patients)

Order CT urography for patients with:

• Age >35 years (particularly >50 years)
• Male gender
• Smoking history
• Occupational chemical exposure
• History of pelvic irradiation
• Chronic UTI or indwelling catheter
• Irritative voiding symptoms
• History of urologic disease
• Gross hematuria (30-40% malignancy risk) 1

Intermediate-Risk Patients

For intermediate-risk patients (some risk factors but not high-risk), the 2025 AUA/SUFU guidelines recommend:

• Renal and bladder ultrasound as first-line imaging 2
• Consider shared decision-making regarding CT urography
• CT urography reserved for high-risk patients 2

Critical Risk Factors for Malignancy

The most important factors that should trigger imaging evaluation include:

• Gross hematuria (visible blood)
• Age >35 years, especially >50 years
• Male gender (OR 2.92 for gross hematuria) 3
• Smoking
• Occupational exposures (chemicals, dyes, rubber, leather)
• Prior chemotherapy (cyclophosphamide) or pelvic radiation
• Chronic indwelling foreign body

Practical Algorithm

1. First: Exclude benign causes

   • UTI (obtain urine culture before antibiotics) 1
   • Recent vigorous exercise
   • Menstruation
   • Recent urologic procedure
   • Trauma

2. Second: Assess risk factors (see above list)

3. Third: Choose imaging based on risk

   • No risk factors + benign cause identified: No imaging 1
   • Intermediate risk: Renal/bladder ultrasound 2
   • High risk or gross hematuria: CT urography 1

Important Caveats

• Anticoagulation does not eliminate the need for evaluation if risk factors are present 1
• Renal parenchymal disease (proteinuria, dysmorphic RBCs, RBC casts) warrants nephrology referral but does not preclude urologic evaluation 1
• Cystoscopy should accompany imaging in intermediate- and high-risk patients, as CT has limited sensitivity for bladder lesions 1, 2
• The 2020 AUA guideline revision specifically moved away from routine CT for all microhematuria due to high costs, limited diagnostic benefit, and radiation exposure 4

Cost and Radiation Considerations

Routine CT urography for low-risk microhematuria represents low-value care. Studies show that 51% of patients with microscopic hematuria received low-value CT urography even after guideline revisions 4. This exposes patients to:

• Unnecessary ionizing radiation (10-30 mSv) 1
• IV contrast risks
• Increased healthcare costs
• Minimal diagnostic yield (0.9% malignancy rate in microscopic hematuria) 3

The key is risk stratification, not reflexive imaging for any trace of blood on urinalysis.